[Sevelamer hydrochloride and vitamin D for controlling serum calcium, phosphorus and bone metabolism in patients undergoing hemodialysis].
Ishida
Mari
M
Yao
Naoyuki
N
Yachiku
Setsuko
S
Anzai
Tsutomu
T
Kobayashi
Takeshi
T
Ishida
Hironori
H
D000368:Aged; D001018:Aortic Diseases / Q000209:etiology / Q000517:prevention & control; D001842:Bone and Bones / Q000378:metabolism*; D002114:Calcinosis / Q000209:etiology / Q000517:prevention & control; D002118:Calcium / Q000097:blood*; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D007011:Hypoparathyroidism / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000097:blood*; D011073:Polyamines / Q000008:administration & dosage*; D020551:Pulse Therapy, Drug; D006435:Renal Dialysis / Q000009:adverse effects*; D000069603:Sevelamer; D014807:Vitamin D / Q000008:administration & dosage*
D011073:Polyamines; D014807:Vitamin D; D010758:Phosphorus; D000069603:Sevelamer; D002118:Calcium